CD27 and polyneuropathy: We retrospectively enrolled 29 patients with anti-MAG polyneuropathy, dividing them into two cohorts: (1) relapse (n = 19), treated with a full course at clinical relapse, or (2) Kim's protocol (n = 10), treated based on peripheral CD27+ B cell monitoring.